Ikeda Y - Search Results

1

Altered membrane proteins and permeability correlate with cardiac dysfunction in cardiomyopathic hamsters.

Ikeda Y, Martone M, Gu Y, Hoshijima M, Thor A, Oh SS, Peterson KL, Ross J Jr. Ikeda Y, et al. Am J Physiol Heart Circ Physiol. 2000 Apr;278(4):H1362-70. doi: 10.1152/ajpheart.2000.278.4.H1362. Am J Physiol Heart Circ Physiol. 2000. PMID: 10749734 Free article.

2

Restoration of deficient membrane proteins in the cardiomyopathic hamster by in vivo cardiac gene transfer.

Ikeda Y, Gu Y, Iwanaga Y, Hoshijima M, Oh SS, Giordano FJ, Chen J, Nigro V, Peterson KL, Chien KR, Ross J Jr. Ikeda Y, et al. Circulation. 2002 Jan 29;105(4):502-8. doi: 10.1161/hc0402.102953. Circulation. 2002. PMID: 11815435

3

Apoptosis and oncosis in the early progression of left ventricular dysfunction in the cardiomyopathic hamster.

Ryoke T, Gu Y, Ikeda Y, Martone ME, Oh SS, Jeon ES, Knowlton KU, Ross J Jr. Ryoke T, et al. Among authors: ikeda y. Basic Res Cardiol. 2002 Jan;97(1):65-75. doi: 10.1007/s395-002-8389-4. Basic Res Cardiol. 2002. PMID: 12004790

4

Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery.

Hoshijima M, Ikeda Y, Iwanaga Y, Minamisawa S, Date MO, Gu Y, Iwatate M, Li M, Wang L, Wilson JM, Wang Y, Ross J Jr, Chien KR. Hoshijima M, et al. Among authors: ikeda y. Nat Med. 2002 Aug;8(8):864-71. doi: 10.1038/nm739. Epub 2002 Jul 22. Nat Med. 2002. PMID: 12134142

5

Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats.

Iwanaga Y, Hoshijima M, Gu Y, Iwatate M, Dieterle T, Ikeda Y, Date MO, Chrast J, Matsuzaki M, Peterson KL, Chien KR, Ross J Jr. Iwanaga Y, et al. Among authors: ikeda y. J Clin Invest. 2004 Mar;113(5):727-36. doi: 10.1172/JCI18716. J Clin Invest. 2004. PMID: 14991071 Free PMC article.

6

Models of dilated cardiomyopathy in the mouse and the hamster.

Ikeda Y, Ross J Jr. Ikeda Y, et al. Curr Opin Cardiol. 2000 May;15(3):197-201. doi: 10.1097/00001573-200005000-00013. Curr Opin Cardiol. 2000. PMID: 10952428 Review.

7

A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia.

Kuo HC, Cheng CF, Clark RB, Lin JJ, Lin JL, Hoshijima M, Nguyêñ-Trân VT, Gu Y, Ikeda Y, Chu PH, Ross J, Giles WR, Chien KR. Kuo HC, et al. Among authors: ikeda y. Cell. 2001 Dec 14;107(6):801-13. doi: 10.1016/s0092-8674(01)00588-8. Cell. 2001. PMID: 11747815 Free article.

8

Heart failure-inducible gene therapy targeting protein phosphatase 1 prevents progressive left ventricular remodeling.

Miyazaki Y, Ikeda Y, Shiraishi K, Fujimoto SN, Aoyama H, Yoshimura K, Inui M, Hoshijima M, Kasahara H, Aoki H, Matsuzaki M. Miyazaki Y, et al. Among authors: ikeda y. PLoS One. 2012;7(4):e35875. doi: 10.1371/journal.pone.0035875. Epub 2012 Apr 27. PLoS One. 2012. PMID: 22558250 Free PMC article.

9

Fibulin-5/DANCE is essential for elastogenesis in vivo.

Nakamura T, Lozano PR, Ikeda Y, Iwanaga Y, Hinek A, Minamisawa S, Cheng CF, Kobuke K, Dalton N, Takada Y, Tashiro K, Ross J Jr, Honjo T, Chien KR. Nakamura T, et al. Among authors: ikeda y. Nature. 2002 Jan 10;415(6868):171-5. doi: 10.1038/415171a. Nature. 2002. PMID: 11805835

10

Toward biologically targeted therapy of calcium cycling defects in heart failure.

Ikeda Y, Hoshijima M, Chien KR. Ikeda Y, et al. Physiology (Bethesda). 2008 Feb;23:6-16. doi: 10.1152/physiol.00033.2007. Physiology (Bethesda). 2008. PMID: 18268360 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,485 results

Search Page

Filters